These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 27722177)
1. Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells. Li J; Yue L; Wang H; Liu C; Liu H; Tao J; Qi W; Wang Y; Zhang W; Fu R; Shao Z J Immunol Res; 2016; 2016():9404705. PubMed ID: 27722177 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes. Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180 [TBL] [Abstract][Full Text] [Related]
3. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome. Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797 [TBL] [Abstract][Full Text] [Related]
4. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA). Li X; Xu F; He Q; Wu L; Zhang Z; Chang C Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647 [TBL] [Abstract][Full Text] [Related]
5. The prevalence and distribution of Th17 and Tc17 cells in patients with thyroid tumor. Jiang G; Ma S; Wei Y; Wu Y; Yu X; Liu H Immunol Lett; 2014 Nov; 162(1 Pt A):68-73. PubMed ID: 25068436 [TBL] [Abstract][Full Text] [Related]
6. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia]. Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of T cell subsets and CD3zeta chain expression in myelodysplastic syndrome patients]. Xu F; Liu T; Zhu HL; Cui X; Xu CG; Mao YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):779-82. PubMed ID: 15631660 [TBL] [Abstract][Full Text] [Related]
8. Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromes. Wang HQ; Shao ZH; Shi J; Cao YR; Liu H; Bai J; Tu MF; Xing LM; Cui ZZ; Liu SH; Sun J; Jia HR; Yang TY Chin Med Sci J; 2006 Jun; 21(2):99-103. PubMed ID: 16845796 [TBL] [Abstract][Full Text] [Related]
9. Th17 and Th1 Lymphocytes Are Correlated with Chronic Periodontitis. Chen XT; Chen LL; Tan JY; Shi DH; Ke T; Lei LH Immunol Invest; 2016; 45(3):243-54. PubMed ID: 27019379 [TBL] [Abstract][Full Text] [Related]
10. Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes. Alfinito F; Sica M; Luciano L; Della Pepa R; Palladino C; Ferrara I; Giani U; Ruggiero G; Terrazzano G Br J Haematol; 2010 Jan; 148(1):90-8. PubMed ID: 19793254 [TBL] [Abstract][Full Text] [Related]
11. Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes. Bouchliou I; Miltiades P; Nakou E; Spanoudakis E; Goutzouvelidis A; Vakalopoulou S; Garypidou V; Kotoula V; Bourikas G; Tsatalas C; Kotsianidis I Clin Immunol; 2011 Jun; 139(3):350-9. PubMed ID: 21444247 [TBL] [Abstract][Full Text] [Related]
12. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes. Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248 [TBL] [Abstract][Full Text] [Related]
13. Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome. Iwase O; Aizawa S; Kuriyama Y; Yaguchi M; Nakano M; Toyama K Ann Hematol; 1995 Dec; 71(6):293-9. PubMed ID: 8534761 [TBL] [Abstract][Full Text] [Related]
14. CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes. Cortez-Espinosa N; Cortés-Garcia JD; Martínez-Leija E; Rodríguez-Rivera JG; Barajas-López C; González-Amaro R; Portales-Pérez DP Hum Immunol; 2015 Sep; 76(9):622-30. PubMed ID: 26386144 [TBL] [Abstract][Full Text] [Related]
15. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients. Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000 [TBL] [Abstract][Full Text] [Related]
16. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627 [TBL] [Abstract][Full Text] [Related]
17. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome]. Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955 [TBL] [Abstract][Full Text] [Related]
18. CD8 Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785 [TBL] [Abstract][Full Text] [Related]
19. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes]. Wu LY; Li X; Chang CK; Ying SX; Pu Q Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133 [TBL] [Abstract][Full Text] [Related]
20. Reduced potency of cytotoxic T lymphocytes from patients with high-risk myelodysplastic syndromes. Sand K; Theorell J; Bruserud Ø; Bryceson YT; Kittang AO Cancer Immunol Immunother; 2016 Sep; 65(9):1135-47. PubMed ID: 27481108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]